Previous studies have shown that ELISA for VCA-IgA has poor sensitivity in diagnosing NPC, while EBNA1-IgA has relatively high sensitivity, especially for the diagnosis of early NPC 19-21. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.